Intracellular- and extracellular-derived Ca2+ influence phospholipase A2-mediated fatty acid release from brain phospholipids

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1791, Issue 8, 2009, Pages 697-705

  Rosa, Angelo O ^a   Rapoport, Stanley I ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Arachidonic acid; Calcium; Docosahexaenoic acid; Endoplasmic reticulum; Phospholipase A2; Signaling

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; PHOSPHOLIPASE A2; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID;

ALZHEIMER DISEASE; BRAIN; BRAIN FUNCTION; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CEREBELLAR ATAXIA; COW; DEPRESSION; DYSTONIA; ENZYME ACTIVITY; EXTRACELLULAR CALCIUM; FATTY ACID SYNTHESIS; HUMAN; MONKEY; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

ANIMALS; BRAIN; CALCIUM; EXTRACELLULAR SPACE; FATTY ACIDS; HUMANS; INTRACELLULAR SPACE; PHOSPHOLIPASES A2; PHOSPHOLIPIDS;

EID: 67650436063     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2009.03.009     Document Type: Review

References (199)

1. Kudo I., and Murakami M. Phospholipase A2 enzymes. Prostagland. Other Lipid Mediat. 68-69 (2002) 3-58
2. Kramer R.M., Hession C., Johansen B., Hayes G., McGray P., Chow E.P., Tizard R., and Pepinsky R.B. Structure and properties of a human non-pancreatic phospholipase A2. J. Biol. Chem. 264 (1989) 5768-5775
3. Karnauchow T.M., and Chan A.C. Characterization of human placental blood vessel phospholipase A2, demonstration of substrate selectivity for arachidonyl-phosphatidylcholine. Int. J. Biochem. 17 (1985) 1317-1319
4. Diez E., Chilton F.H., Stroup G., Mayer R.J., Winkler J.D., and Fonteh A.N. Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate. Biochem. J. 301 Pt 3 (1994) 721-726
5. Schaloske R.H., and Dennis E.A. The phospholipase A2 superfamily and its group numbering system. Biochim. Biophys. Acta 1761 (2006) 1246-1259
6. Stafforini D.M. Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2). Cardiovasc. Drugs Ther. 23 (2009) 73-83
7. Farooqui A.A., and Horrocks L.A. Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia. Neuroscientist 7 (2001) 232-245
8. Derewenda Z.S., and Derewenda U. The structure and function of platelet-activating factor acetylhydrolases. Cell. Mol. Life Sci. 54 (1998) 446-455
9. Abe A., Hiraoka M., and Shayman J.A. Positional specificity of lysosomal phospholipase A2. J. Lipid Res. 47 (2006) 2268-2279
10. Bosetti F. Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse models. J. Neurochem. 102 (2007) 577-586
11. Bazan N.G. Lipid signaling in neural plasticity, brain repair, and neuroprotection. Mol. Neurobiol. 32 (2005) 89-103
12. Akbar M., Calderon F., Wen Z., and Kim H.Y. a positive modulator of Akt signaling in neuronal survival. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 10858-10863
13. Griffin D.E., Wesselingh S.L., and McArthur J.C. Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann. Neurol. 35 (1994) 592-597
14. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J. Neuropathol. Exp. Neurol. 63 (2004) 901-910
15. Adibhatla R.M., and Hatcher J.F. Phospholipase A(2), reactive oxygen species, and lipid peroxidation in CNS pathologies. BMB Rep. 41 (2008) 560-567
16. Farooqui A.A., and Horrocks L.A. Brain phospholipases A2: a perspective on the history. Prostaglandins. Leukot. Essent. Fatty Acids 71 (2004) 161-169
17. Ong W.Y., Sandhya T.L., Horrocks L.A., and Farooqui A.A. Distribution of cytoplasmic phospholipase A2 in the normal rat brain. J. Hirnforsch. 39 (1999) 391-400
18. Ong W.Y., Yeo J.F., Ling S.F., and Farooqui A.A. Distribution of calcium-independent phospholipase A2 (iPLA 2) in monkey brain. J. Neurocytol. 34 (2005) 447-458
19. Abe A., Hiraoka M., Wild S., Wilcoxen S.E., Paine III R., and Shayman J.A. Lysosomal phospholipase A2 is selectively expressed in alveolar macrophages. J. Biol. Chem. 279 (2004) 42605-42611
20. Bao S., Jin C., Zhang S., Turk J., Ma Z., and Ramanadham S. Beta-cell calcium-independent group VIA phospholipase A(2) (iPLA(2)beta): tracking iPLA(2)beta movements in response to stimulation with insulin secretagogues in INS-1 cells. Diabetes 53 Suppl. 1 (2004) S186-S189
21. J.E. Burke, E.A. Dennis, Phospholipase A2 structure/function, mechanism and signaling, J. Lipid Res. (in press) doi:10.1194/jlr.R800033-JLR200.
22. Shinozaki K., and Waite M. A novel phosphatidylglycerol-selective phospholipase A2 from macrophages. Biochemistry 38 (1999) 1669-1675
23. Kim T.S., Sundaresh C.S., Feinstein S.I., Dodia C., Skach W.R., Jain M.K., Nagase T., Seki N., Ishikawa K., Nomura N., and Fisher A.B. Identification of a human cDNA clone for lysosomal type Ca2+-independent phospholipase A2 and properties of the expressed protein. J. Biol. Chem. 272 (1997) 2542-2550
24. Turk J., and Ramanadham S. The expression and function of a group VIA calcium-independent phospholipase A2 (iPLA2beta) in beta-cells. Can. J. Physiol. Pharmacol. 82 (2004) 824-832
25. Yang H.C., Mosior M., Johnson C.A., Chen Y., and Dennis E.A. Group-specific assays that distinguish between the four major types of mammalian phospholipase A2. Anal. Biochem. 269 (1999) 278-288
26. Laychock S.G. Phospholipase A2 activity in pancreatic islets is calcium-dependent and stimulated by glucose. Cell Calcium 3 (1982) 43-54
27. Clapham D.E. Calcium signaling. Cell 80 (1995) 259-268
28. Nardicchi V., Macchioni L., Ferrini M., and Goracci G. The presence of a secretory phospholipase A2 in the nuclei of neuronal and glial cells of rat brain cortex. Biochim. Biophys. Acta 1771 (2007) 1345-1352
29. Murakami M., Kambe T., Shimbara S., Yamamoto S., Kuwata H., and Kudo I. Functional association of type IIA secretory phospholipase A(2) with the glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan in the cyclooxygenase-2-mediated delayed prostanoid-biosynthetic pathway. J. Biol. Chem. 274 (1999) 29927-29936
30. Mathisen G.H., Thorkildsen I.H., and Paulsen R.E. Secretory PLA2-IIA and ROS generation in peripheral mitochondria are critical for neuronal death. Brain Res. 1153 (2007) 43-51
31. Underwood K.W., Song C., Kriz R.W., Chang X.J., Knopf J.L., and Lin L.L. A novel calcium-independent phospholipase A2, cPLA2-gamma, that is prenylated and contains homology to cPLA2. J. Biol. Chem. 273 (1998) 21926-21932
32. Chiba H., Michibata H., Wakimoto K., Seishima M., Kawasaki S., Okubo K., Mitsui H., Torii H., and Imai Y. Cloning of a gene for a novel epithelium-specific cytosolic phospholipase A2, cPLA2delta, induced in psoriatic skin. J. Biol. Chem. 279 (2004) 12890-12897
33. Pickard R.T., Strifler B.A., Kramer R.M., and Sharp J.D. Molecular cloning of two new human paralogs of 85-kDa cytosolic phospholipase A2. J. Biol. Chem. 274 (1999) 8823-8831
34. Song C., Chang X.J., Bean K.M., Proia M.S., Knopf J.L., and Kriz R.W. Molecular characterization of cytosolic phospholipase A2-beta. J. Biol. Chem. 274 (1999) 17063-17067
35. Sharp J.D., White D.L., Chiou X.G., Goodson T., Gamboa G.C., McClure D., Burgett S., Hoskins J., Skatrud P.L., Sportsman J.R., et al. Molecular cloning and expression of human Ca(2+)-sensitive cytosolic phospholipase A2. J. Biol. Chem. 266 (1991) 14850-14853
36. Clark J.D., Lin L.L., Kriz R.W., Ramesha C.S., Sultzman L.A., Lin A.Y., Milona N., and Knopf J.L. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell 65 (1991) 1043-1051
37. Ohto T., Uozumi N., Hirabayashi T., and Shimizu T. Identification of novel cytosolic phospholipase A(2)s, murine cPLA(2){delta}, {epsilon}, and {zeta}, which form a gene cluster with cPLA(2){beta}. J. Biol. Chem. 280 (2005) 24576-24583
38. Ghosh M., Tucker D.E., Burchett S.A., and Leslie C.C. Properties of the Group IV phospholipase A2 family. Prog. Lipid Res. 45 (2006) 487-510
39. Sedgwick S.G., and Smerdon S.J. The ankyrin repeat: a diversity of interactions on a common structural framework. Trends Biochem. Sci. 24 (1999) 311-316
40. Ma Z., Wang X., Nowatzke W., Ramanadham S., and Turk J. Human pancreatic islets express mRNA species encoding two distinct catalytically active isoforms of group VI phospholipase A2 (iPLA2) that arise from an exon-skipping mechanism of alternative splicing of the transcript from the iPLA2 gene on chromosome 22q13.1. J. Biol. Chem. 274 (1999) 9607-9616
41. Mancuso D.J., Jenkins C.M., and Gross R.W. The genomic organization, complete mRNA sequence, cloning, and expression of a novel human intracellular membrane-associated calcium-independent phospholipase A(2). J. Biol. Chem. 275 (2000) 9937-9945
42. Wolf M.J., Wang J., Turk J., and Gross R.W. Depletion of intracellular calcium stores activates smooth muscle cell calcium-independent phospholipase A2. A novel mechanism underlying arachidonic acid mobilization. J. Biol. Chem. 272 (1997) 1522-1526
43. Wolf M.J., and Gross R.W. The calcium-dependent association and functional coupling of calmodulin with myocardial phospholipase A2. Implications for cardiac cycle-dependent alterations in phospholipolysis. J. Biol. Chem. 271 (1996) 20989-20992
44. Jenkins C.M., Wolf M.J., Mancuso D.J., and Gross R.W. Identification of the calmodulin-binding domain of recombinant calcium-independent phospholipase A2beta. implications for structure and function. J. Biol. Chem. 276 (2001) 7129-7135
45. Moro F., Arrigo G., Fogli A., Bernard L., and Carrozzo R. The beta and gamma subunits of the human platelet-activating factor acetyl hydrolase isoform Ib (PAFAH1B2 and PAFAH1B3) map to chromosome 11q23 and 19q13.1, respectively. Genomics 51 (1998) 157-159
46. Ho Y.S., Swenson L., Derewenda U., Serre L., Wei Y., Dauter Z., Hattori M., Adachi T., Aoki J., Arai H., Inoue K., and Derewenda Z.S. Brain acetylhydrolase that inactivates platelet-activating factor is a G-protein-like trimer. Nature 385 (1997) 89-93
47. Rice S.Q., Southan C., Boyd H.F., Terrett J.A., MacPhee C.H., Moores K., Gloger I.S., and Tew D.G. Expression, purification and characterization of a human serine-dependent phospholipase A2 with high specificity for oxidized phospholipids and platelet activating factor. Biochem. J. 330 Pt 3 (1998) 1309-1315
48. Ackermann E.J., and Dennis E.A. Mammalian calcium-independent phospholipase A2. Biochim. Biophys. Acta 1259 (1995) 125-136
49. Yang H.C., Mosior M., Ni B., and Dennis E.A. Regional distribution, ontogeny, purification, and characterization of the Ca2+-independent phospholipase A2 from rat brain. J. Neurochem. 73 (1999) 1278-1287
50. Stephenson D.T., Lemere C.A., Selkoe D.J., and Clemens J.A. Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol. Dis. 3 (1996) 51-63
51. Hirashima Y., Farooqui A.A., Mills J.S., and Horrocks L.A. Identification and purification of calcium-independent phospholipase A2 from bovine brain cytosol. J. Neurochem. 59 (1992) 708-714
52. Yang H.C., Farooqui A.A., and Horrocks L.A. Effects of sialic acid and sialoglycoconjugates on cytosolic phospholipases A2 from bovine brain. Biochem. Biophys. Res. Commun. 199 (1994) 1158-1166
53. Xu J., Yu S., Sun A.Y., and Sun G.Y. Oxidant-mediated AA release from astrocytes involves cPLA(2) and iPLA(2). Free Radic. Biol. Med. 34 (2003) 1531-1543
54. Neuringer M., Anderson G.J., and Connor W.E. The essentiality of n-3 fatty acids for the development and function of the retina and brain. Annu. Rev. Nutr. 8 (1988) 517-541
55. Sprecher H. Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim. Biophys. Acta 1486 (2000) 219-231
56. Shikano M., Masuzawa Y., Yazawa K., Takayama K., Kudo I., and Inoue K. Complete discrimination of docosahexaenoate from arachidonate by 85 kDa cytosolic phospholipase A2 during the hydrolysis of diacyl- and alkenylacylglycerophosphoethanolamine. Biochim. Biophys. Acta 1212 (1994) 211-216
57. Kaufmann W.E., Worley P.F., Pegg J., Bremer M., and Isakson P. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 2317-2321
58. Shimizu T., and Wolfe L.S. Arachidonic acid cascade and signal transduction. J. Neurochem. 55 (1990) 1-15
59. Scuri R., Mozzachiodi R., and Brunelli M. Role for calcium signaling and arachidonic acid metabolites in the activity-dependent increase of AHP amplitude in leech T sensory neurons. J. Neurophysiol. 94 (2005) 1066-1073
60. Ojeda S.R., Urbanski H.F., Junier M.P., and Capdevila J. The role of arachidonic acid and its metabolites in the release of neuropeptides. Ann. N. Y. Acad. Sci. 559 (1989) 192-207
61. Striggow F., and Ehrlich B.E. Regulation of intracellular calcium release channel function by arachidonic acid and leukotriene B4. Biochem. Biophys. Res. Commun. 237 (1997) 413-418
62. Cowell A.M., and Buckingham J.C. Eicosanoids and the hypothalamo-pituitary axis. Prostaglandins. Leukot. Essent. Fat Acids 36 (1989) 235-250
63. Smith H.S. Arachidonic acid pathways in nociception. J. Support. Oncol. 4 (2006) 277-287
64. Pickard J.D. Role of prostaglandins and arachidonic acid derivatives in the coupling of cerebral blood flow to cerebral metabolism. J. Cereb. Blood Flow Metab. 1 (1981) 361-384
65. Vanecek J., and Vollrath L. Melatonin modulates diacylglycerol and arachidonic acid metabolism in the anterior pituitary of immature rats. Neurosci. Lett. 110 (1990) 199-203
66. Baile C.A., Simpson C.W., Bean S.M., McLaughlin C.L., and Jacobs H.L. Prostaglandins and food intake of rats: a component of energy balance regulation?. Physiol. Behav. 10 (1973) 1077-1085
67. Fang K.M., Chang W.L., Wang S.M., Su M.J., and Wu M.L. Arachidonic acid induces both Na+ and Ca2+ entry resulting in apoptosis. J. Neurochem. 104 (2008) 1177-1189
68. McCown T.J., Knapp D.J., and Crews F.T. Inferior collicular seizure generalization produces site-selective cortical induction of cyclooxygenase 2 (COX-2). Brain Res. 767 (1997) 370-374
69. Wang Q., Tang X.N., and Yenari M.A. The inflammatory response in stroke. J. Neuroimmunol. 184 (2007) 53-68
70. Almer G., Guegan C., Teismann P., Naini A., Rosoklija G., Hays A.P., Chen C., and Przedborski S. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann. Neurol. 49 (2001) 176-185
71. Bazan N.G., Colangelo V., and Lukiw W.J. Prostaglandins and other lipid mediators in Alzheimer's disease. Prostaglandins. Other Lipid Mediat. 68-69 (2002) 197-210
72. Teismann P., Vila M., Choi D.K., Tieu K., Wu D.C., Jackson-Lewis V., and Przedborski S. COX-2 and neurodegeneration in Parkinson's disease. Ann. N. Y. Acad. Sci. 991 (2003) 272-277
73. Muller N., Riedel M., Scheppach C., Brandstatter B., Sokullu S., Krampe K., Ulmschneider M., Engel R.R., Moller H.J., and Schwarz M.J. Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am. J. Psychiatry 159 (2002) 1029-1034
74. Rao J.S., Lee H.J., Rapoport S.I., and Bazinet R.P. Mode of action of mood stabilizers: is the arachidonic acid cascade a common target?. Mol. Psychiatry 13 (2008) 585-596
75. Contreras M.A., and Rapoport S.I. Recent studies on interactions between n-3 and n-6 polyunsaturated fatty acids in brain and other tissues. Curr. Opin. Lipidol. 13 (2002) 267-272
76. Sublette M.E., Bosetti F., DeMar J.C., Ma K., Bell J.M., Fagin-Jones S., Russ M.J., and Rapoport S.I. Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute mania. Bipolar. Disord. 9 (2007) 759-765
77. Adams P.B., Lawson S., Sanigorski A., and Sinclair A.J. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 31 Suppl (1996) S157-S161
78. Conklin S.M., Manuck S.B., Yao J.K., Flory J.D., Hibbeln J.R., and Muldoon M.F. High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism. Psychosom. Med. 69 (2007) 932-934
79. Strokin M., Sergeeva M., and Reiser G. Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+. Br. J. Pharmacol. 139 (2003) 1014-1022
80. Rapoport S.I., Rao J.S., and Igarashi M. Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver. Prostaglandins. Leukot. Essent. Fatty Acids 77 (2007) 251-261
81. Burdge G.C., and Wootton S.A. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br. J. Nutr. 88 (2002) 411-420
82. DeMar Jr. J.C., Ma K., Bell J.M., and Rapoport S.I. Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. J. Neurochem. 91 (2004) 1125-1137
83. Rao J.S., Ertley R.N., DeMar Jr. J.C., Rapoport S.I., Bazinet R.P., and Lee H.J. Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex. Mol. Psychiatry 12 (2007) 151-157
84. Fedorova I., Hussein N., Di Martino C., Moriguchi T., Hoshiba J., Majchrzak S., and Salem Jr. N. An n-3 fatty acid deficient diet affects mouse spatial learning in the Barnes circular maze. Prostaglandins. Leukot. Essent. Fatty Acids 77 (2007) 269-277
85. Xiao Y., Wang L., Xu R.J., and Chen Z.Y. DHA depletion in rat brain is associated with impairment on spatial learning and memory. Biomed. Environ. Sci. 19 (2006) 474-480
86. Judge M.P., Harel O., and Lammi-Keefe C.J. Maternal consumption of a docosahexaenoic acid-containing functional food during pregnancy: benefit for infant performance on problem-solving but not on recognition memory tasks at age 9 mo. Am. J. Clin. Nutr. 85 (2007) 1572-1577
87. Kidd P.M. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern. Med. Rev. 12 (2007) 207-227
88. Parker G., Gibson N.A., Brotchie H., Heruc G., Rees A.M., and Hadzi-Pavlovic D. Omega-3 fatty acids and mood disorders. Am. J. Psychiatry 163 (2006) 969-978
89. DeMar Jr. J.C., Ma K., Bell J.M., Igarashi M., Greenstein D., and Rapoport S.I. One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J. Lipid Res. 47 (2006) 172-180
90. Serhan C.N., Arita M., Hong S., and Gotlinger K. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 39 (2004) 1125-1132
91. Serhan C.N., Gotlinger K., Hong S., and Arita M. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins. Other Lipid Mediat. 73 (2004) 155-172
92. Serhan C.N., Hong S., Gronert K., Colgan S.P., Devchand P.R., Mirick G., and Moussignac R.L. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196 (2002) 1025-1037
93. Hong S., Gronert K., Devchand P.R., Moussignac R.L., and Serhan C.N. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J. Biol. Chem. 278 (2003) 14677-14687
94. Marcheselli V.L., Hong S., Lukiw W.J., Tian X.H., Gronert K., Musto A., Hardy M., Gimenez J.M., Chiang N., Serhan C.N., and Bazan N.G. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 278 (2003) 43807-43817
95. Okuda S., Saito H., and Katsuki H. Arachidonic acid: toxic and trophic effects on cultured hippocampal neurons. Neuroscience 63 (1994) 691-699
96. Katsuki H., and Okuda S. Arachidonic acid as a neurotoxic and neurotrophic substance. Prog. Neurobiol. 46 (1995) 607-636
97. Nishizaki T., Nomura T., Matsuoka T., Enikolopov G., and Sumikawa K. Arachidonic acid induces a long-lasting facilitation of hippocampal synaptic transmission by modulating PKC activity and nicotinic ACh receptors. Brain Res. Mol. Brain Res. 69 (1999) 263-272
98. Bazan N.G. Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol. 15 (2005) 159-166
99. Bazan N.G. Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr. Opin. Clin. Nutr. Metab. Care 10 (2007) 136-141
100. Sergeeva M., Strokin M., and Reiser G. Regulation of intracellular calcium levels by polyunsaturated fatty acids, arachidonic acid and docosahexaenoic acid, in astrocytes: possible involvement of phospholipase A2. Reprod. Nutr. Dev. 45 (2005) 633-646
101. Garcia M.C., and Kim H.Y. Mobilization of arachidonate and docosahexaenoate by stimulation of the 5-HT2A receptor in rat C6 glioma cells. Brain Res. 768 (1997) 43-48
102. Jones C.R., Arai T., and Rapoport S.I. Evidence for the involvement of docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse. Neurochem. Res. 22 (1997) 663-670
103. DeGeorge J.J., Nariai T., Yamazaki S., Williams W.M., and Rapoport S.I. Arecoline-stimulated brain incorporation of intravenously administered fatty acids in unanesthetized rats. J. Neurochem. 56 (1991) 352-355
104. Nishikawa M., Kimura S., and Akaike N. Facilitatory effect of docosahexaenoic acid on N-methyl-d-aspartate response in pyramidal neurones of rat cerebral cortex. J. Physiol. 475 (1994) 83-93
105. Strokin M., Sergeeva M., and Reiser G. Prostaglandin synthesis in rat brain astrocytes is under the control of the n-3 docosahexaenoic acid, released by group VIB calcium-independent phospholipase A2. J. Neurochem. 102 (2007) 1771-1782
106. Aires V., Hichami A., Filomenko R., Ple A., Rebe C., Bettaieb A., and Khan N.A. Docosahexaenoic acid induces increases in [Ca2+]i via inositol 1,4,5-triphosphate production and activates protein kinase C gamma and -delta via phosphatidylserine binding site: implication in apoptosis in U937 cells. Mol. Pharmacol. 72 (2007) 1545-1556
107. Yu Z., Luo H., Fu W., and Mattson M.P. The endoplasmic reticulum stress-responsive protein GRP78 protects neurons against excitotoxicity and apoptosis: suppression of oxidative stress and stabilization of calcium homeostasis. Exp. Neurol. 155 (1999) 302-314
108. Paschen W. Endoplasmic reticulum: a primary target in various acute disorders and degenerative diseases of the brain. Cell Calcium 34 (2003) 365-383
109. Paschen W. Endoplasmic reticulum dysfunction in brain pathology: critical role of protein synthesis. Curr. Neurovasc. Res. 1 (2004) 173-181
110. Pizzo P., and Pozzan T. Mitochondria-endoplasmic reticulum choreography: structure and signaling dynamics. Trends Cell Biol. 17 (2007) 511-517
111. Wu J., Holstein J.D., Upadhyay G., Lin D.T., Conway S., Muller E., and Lechleiter J.D. Purinergic receptor-stimulated IP3-mediated Ca2+ release enhances neuroprotection by increasing astrocyte mitochondrial metabolism during aging. J. Neurosci. 27 (2007) 6510-6520
112. Egea J., Rosa A.O., Cuadrado A., Garcia A.G., and Lopez M.G. Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress. J. Neurochem. 102 (2007) 1842-1852
113. Gray J.J., Bickler P.E., Fahlman C.S., Zhan X., and Schuyler J.A. Isoflurane neuroprotection in hypoxic hippocampal slice cultures involves increases in intracellular Ca2+ and mitogen-activated protein kinases. Anesthesiology 102 (2005) 606-615
114. Bickler P.E., and Buck L.T. Effects of fructose-1,6-bisphosphate on glutamate release and ATP loss from rat brain slices during hypoxia. J. Neurochem. 67 (1996) 1463-1468
115. Bickler P.E., and Fahlman C.S. The inhaled anesthetic, isoflurane, enhances Ca2+-dependent survival signaling in cortical neurons and modulates MAP kinases, apoptosis proteins and transcription factors during hypoxia. Anesth. Analg. 103 (2006) 419-429 (table of contents)
116. Beskina O., Miller A., Mazzocco-Spezzia A., Pulina M.V., and Golovina V.A. Mechanisms of interleukin-1beta-induced Ca2+ signals in mouse cortical astrocytes: roles of store- and receptor-operated Ca2+ entry. Am. J. Physiol., Cell Physiol. 293 (2007) C1103-C1111
117. Lukiw W.J., Cui J.G., Marcheselli V.L., Bodker M., Botkjaer A., Gotlinger K., Serhan C.N., and Bazan N.G. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J. Clin. Invest. 115 (2005) 2774-2783
118. McGeer P.L., Schulzer M., and McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47 (1996) 425-432
119. Price D.L., Tanzi R.E., Borchelt D.R., and Sisodia S.S. Alzheimer's disease: genetic studies and transgenic models. Annu. Rev. Genet. 32 (1998) 461-493
120. Kadoyama K., Takahashi Y., Higashida H., Tanabe T., and Yoshimoto T. Cyclooxygenase-2 stimulates production of amyloid beta-peptide in neuroblastoma × glioma hybrid NG108-15 cells. Biochem. Biophys. Res. Commun. 281 (2001) 483-490
121. Peterson B., Knotts T., and Cummings B.S. Involvement of Ca2+-independent phospholipase A2 isoforms in oxidant-induced neural cell death. Neurotoxicology 28 (2007) 150-160
122. Kinsey G.R., McHowat J., Patrick K.S., and Schnellmann R.G. Role of Ca2+-independent phospholipase A2gamma in Ca2+-induced mitochondrial permeability transition. J. Pharmacol. Exp. Ther. 321 (2007) 707-715
123. Atsumi G., Murakami M., Kojima K., Hadano A., Tajima M., and Kudo I. Distinct roles of two intracellular phospholipase A2s in fatty acid release in the cell death pathway. Proteolytic fragment of type IVA cytosolic phospholipase A2alpha inhibits stimulus-induced arachidonate release, whereas that of type VI Ca2+-independent phospholipase A2 augments spontaneous fatty acid release. J. Biol. Chem. 275 (2000) 18248-18258
124. Balsinde J., Perez R., and Balboa M.A. Calcium-independent phospholipase A2 and apoptosis. Biochim. Biophys. Acta 1761 (2006) 1344-1350
125. Chang M.C., Bell J.M., Purdon A.D., Chikhale E.G., and Grange E. Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment. Neurochem. Res. 24 (1999) 399-406
126. Chang M.C., Grange E., Rabin O., Bell J.M., Allen D.D., and Rapoport S.I. Lithium decreases turnover of arachidonate in several brain phospholipids. Neurosci. Lett. 220 (1996) 171-174
127. Taylor A.L., Bonventre J.V., Uliasz T.F., Hewett J.A., and Hewett S.J. Cytosolic phospholipase A2 alpha inhibition prevents neuronal NMDA receptor-stimulated arachidonic acid mobilization and prostaglandin production but not subsequent cell death. J. Neurochem. 106 (2008) 1828-1840
128. Pellerin L., and Wolfe L.S. Release of arachidonic acid by NMDA-receptor activation in the rat hippocampus. Neurochem. Res. 16 (1991) 983-989
129. Taylor M., Shajahan P., and Lawrie S.M. Comparing the use and discontinuation of antipsychotics in clinical practice: an observational study. J. Clin. Psychiatry 69 (2008) 240-245
130. Basselin M., Chang L., Bell J.M., and Rapoport S.I. Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats. Neuropsychopharmacology 31 (2006) 1659-1674
131. Basselin M., Chang L., Chen M., Bell J.M., and Rapoport S.I. Chronic administration of valproic acid reduces brain NMDA signaling via arachidonic acid in unanesthetized rats. Neurochem. Res. 33 (2008) 2229-2240
132. Basselin M., Villacreses N.E., Chen M., Bell J.M., and Rapoport S.I. Chronic carbamazepine administration reduces N-methyl-d-aspartate receptor-initiated signaling via arachidonic acid in rat brain. Biol. Psychiatry 62 (2007) 934-943
133. Sanfeliu C., Hunt A., and Patel A.J. Exposure to N-methyl-d-aspartate increases release of arachidonic acid in primary cultures of rat hippocampal neurons and not in astrocytes. Brain Res. 526 (1990) 241-248
134. Felder C.C., Kanterman R.Y., Ma A.L., and Axelrod J. Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 2187-2191
135. Wolf R.A., and Gross R.W. Identification of neutral active phospholipase C which hydrolyzes choline glycerophospholipids and plasmalogen selective phospholipase A2 in canine myocardium. J. Biol. Chem. 260 (1985) 7295-7303
136. Basheer R., Arrigoni E., Thatte H.S., Greene R.W., Ambudkar I.S., and McCarley R.W. Adenosine induces inositol 1,4,5-trisphosphate receptor-mediated mobilization of intracellular calcium stores in basal forebrain cholinergic neurons. J. Neurosci. 22 (2002) 7680-7686
137. Doengi M., Deitmer J.W., and Lohr C. New evidence for purinergic signaling in the olfactory bulb: A2A and P2Y1 receptors mediate intracellular calcium release in astrocytes. Faseb. J. 22 (2008) 2368-2378
138. Yamamoto K., Hashimoto K., Isomura Y., Shimohama S., and Kato N. An IP3-assisted form of Ca2+-induced Ca2+ release in neocortical neurons. NeuroReport 11 (2000) 535-539
139. Arce C., Del Campo A.B., Figueroa S., Lopez E., Aranguez I., Oset-Gasque M.J., and Gonzalez M.P. Expression and functional properties of group I metabotropic glutamate receptors in bovine chromaffin cells. J. Neurosci. Res. 75 (2004) 182-193
140. Hayashi T., Kagaya A., Takebayashi M., Oyamada T., Inagaki M., Tawara Y., Yokota N., Horiguchi J., Su T.P., and Yamawaki S. Effect of dantrolene on KCl- or NMDA-induced intracellular Ca2+ changes and spontaneous Ca2+ oscillation in cultured rat frontal cortical neurons. J. Neural. Transm. 104 (1997) 811-824
141. Emptage N., Bliss T.V., and Fine A. Single synaptic events evoke NMDA receptor-mediated release of calcium from internal stores in hippocampal dendritic spines. Neuron 22 (1999) 115-124
142. Morton-Jones R.T., Cannell M.B., and Housley G.D. Ca2+ entry via AMPA-type glutamate receptors triggers Ca2+-induced Ca2+ release from ryanodine receptors in rat spiral ganglion neurons. Cell Calcium 43 (2008) 356-366
143. MacMillan D., Chalmers S., Muir T.C., and McCarron J.G. IP3-mediated Ca2+ increases do not involve the ryanodine receptor, but ryanodine receptor antagonists reduce IP3-mediated Ca2+ increases in guinea-pig colonic smooth muscle cells. J. Physiol. 569 (2005) 533-544
144. Inesi G., Hua S., Xu C., Ma H., Seth M., Prasad A.M., and Sumbilla C. Studies of Ca2+ ATPase (SERCA) inhibition. J. Bioenerg. Biomembr. 37 (2005) 365-368
145. Nowatzke W., Ramanadham S., Ma Z., Hsu F.F., Bohrer A., and Turk J. Mass spectrometric evidence that agents that cause loss of Ca2+ from intracellular compartments induce hydrolysis of arachidonic acid from pancreatic islet membrane phospholipids by a mechanism that does not require a rise in cytosolic Ca2+ concentration. Endocrinology 139 (1998) 4073-4085
146. Lei X., Zhang S., Bohrer A., Bao S., Song H., and Ramanadham S. The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase. Biochemistry 46 (2007) 10170-10185
147. Koizumi S., Saito Y., Nakazawa K., Nakajima K., Sawada J.I., Kohsaka S., Illes P., and Inoue K. Spatial and temporal aspects of Ca2+ signaling mediated by P2Y receptors in cultured rat hippocampal astrocytes. Life Sci. 72 (2002) 431-442
148. Poulsen K.A., Pedersen S.F., Kolko M., and Lambert I.H. Induction of group VIA phospholipase A2 activity during in vitro ischemia in C2C12 myotubes is associated with changes in the level of its splice variants. Am. J. Physiol., Cell Physiol. 293 (2007) C1605-C1615
149. Farias S.E., Basselin M., Chang L., Heidenreich K.A., Rapoport S.I., and Murphy R.C. Formation of eicosanoids, E2/D2 isoprostanes, and docosanoids following decapitation-induced ischemia, measured in high-energy-microwaved rat brain. J. Lipid Res. 49 (2008) 1990-2000
150. Larsen G.A., Skjellegrind H.K., Moe M.C., Vinje M.L., and Berg-Johnsen J. Endoplasmic reticulum dysfunction and Ca2+ deregulation in isolated CA1 neurons during oxygen and glucose deprivation. Neurochem. Res. 30 (2005) 651-659
151. Wang C., Nguyen H.N., Maguire J.L., and Perry D.C. Role of intracellular calcium stores in cell death from oxygen-glucose deprivation in a neuronal cell line. J. Cereb. Blood Flow Metab. 22 (2002) 206-214
152. Kachoei B.A., Knox R.J., Uthuza D., Levy S., Kaczmarek L.K., and Magoski N.S. A store-operated Ca(2+) influx pathway in the bag cell neurons of Aplysia. J. Neurophysiol. 96 (2006) 2688-2698
153. Singaravelu K., Lohr C., and Deitmer J.W. Regulation of store-operated calcium entry by calcium-independent phospholipase A2 in rat cerebellar astrocytes. J. Neurosci. 26 (2006) 9579-9592
154. Corbett E.F., and Michalak M. Calcium, a signaling molecule in the endoplasmic reticulum?. Trends Biochem. Sci. 25 (2000) 307-311
155. Bhattacharjee A.K., Chang L., White L., Bazinet R.P., and Rapoport S.I. Imaging apomorphine stimulation of brain arachidonic acid signaling via D2-like receptors in unanesthetized rats. Psychopharmacology (Berl). 197 (2008) 557-566
156. Bhattacharjee A.K., Chang L., White L., Bazinet R.P., and Rapoport S.I.
157. Bhattacharjee A.K., Chang L., Lee H.J., Bazinet R.P., Seemann R., and Rapoport S.I. D2 but not D1 dopamine receptor stimulation augments brain signaling involving arachidonic acid in unanesthetized rats. Psychopharmacology (Berl). 180 (2005) 735-742
158. Qu Y., Villacreses N., Murphy D.L., and Rapoport S.I. 5-HT2A/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter. Psychopharmacology (Berl). 180 (2005) 12-20
159. Neve K.A., Seamans J.K., and Trantham-Davidson H. Dopamine receptor signaling. J. Recept. Signal Transduct. Res. 24 (2004) 165-205
160. Day M., Olson P.A., Platzer J., Striessnig J., and Surmeier D.J. Stimulation of 5-HT(2) receptors in prefrontal pyramidal neurons inhibits Ca(v)1.2 L type Ca(2+) currents via a PLCbeta/IP3/calcineurin signaling cascade. J. Neurophysiol. 87 (2002) 2490-2504
161. Fisher S.K., Domask L.M., and Roland R.M. Muscarinic receptor regulation of cytoplasmic Ca2+ concentrations in human SK-N-SH neuroblastoma cells: Ca2+ requirements for phospholipase C activation. Mol. Pharmacol. 35 (1989) 195-204
162. Ferrier G.R., Redondo I., Zhu J., and Murphy M.G. Differential effects of docosahexaenoic acid on contractions and L-type Ca2+ current in adult cardiac myocytes. Cardiovasc. Res. 54 (2002) 601-610
163. Green K.N., Martinez-Coria H., Khashwji H., Hall E.B., Yurko-Mauro K.A., Ellis L., and LaFerla F.M. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J. Neurosci. 27 (2007) 4385-4395
164. Green K.N., Smith I.F., and Laferla F.M. Role of calcium in the pathogenesis of Alzheimer's disease and transgenic models. Subcell Biochem. 45 (2007) 507-521
165. Mattson M.P., and Chan S.L. Neuronal and glial calcium signaling in Alzheimer's disease. Cell Calcium 34 (2003) 385-397
166. Esposito G., Giovacchini G., Liow J.S., Bhattacharjee A.K., Greenstein D., Schapiro M., Hallett M., Herscovitch P., Eckelman W.C., Carson R.E., and Rapoport S.I. Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET. J. Nucl. Med. 49 (2008) 1414-1421
167. Rosenberger T.A., Villacreses N.E., Hovda J.T., Bosetti F., Weerasinghe G., Wine R.N., Harry G.J., and Rapoport S.I. Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. J. Neurochem. 88 (2004) 1168-1178
168. Dinarello C.A. Biology of interleukin 1. Faseb J. 2 (1988) 108-115
169. McGeer E.G., and McGeer P.L. Inflammatory processes in Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 (2003) 741-749
170. Sun L.L., Cheng C., Liu H.O., Shen C.C., Xiao F., Qin J., Yang J.L., and Shen A.G. Src suppressed C kinase substrate regulates the lipopolysaccharide-induced TNF-alpha biosynthesis in rat astrocytes. J. Mol. Neurosci. 32 (2007) 16-24
171. Scheuer K., Maras A., Gattaz W.F., Cairns N., Forstl H., and Muller W.E. Cortical NMDA receptor properties and membrane fluidity are altered in Alzheimer's disease. Dementia 7 (1996) 210-214
172. Shelat P.B., Chalimoniuk M., Wang J.H., Strosznajder J.B., Lee J.C., Sun A.Y., Simonyi A., and Sun G.Y. Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons. J. Neurochem. 106 (2008) 45-55
173. Conquer J.A., Tierney M.C., Zecevic J., Bettger W.J., and Fisher R.H. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 35 (2000) 1305-1312
174. Bezprozvanny I., and Mattson M.P. Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci. 31 (2008) 454-463
175. Lim G.P., Calon F., Morihara T., Yang F., Teter B., Ubeda O., Salem Jr. N., Frautschy S.A., and Cole G.M. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J. Neurosci. 25 (2005) 3032-3040
176. Pringle A.K. In, out, shake it all about: elevation of [Ca2+]i during acute cerebral ischaemia. Cell Calcium 36 (2004) 235-245
177. Sattler R., and Tymianski M. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol. Neurobiol. 24 (2001) 107-129
178. Chang Y.C., Kim H.W., Rapoport S.I., and Rao J.S. Chronic NMDA administration increases neuroinflammatory markers in rat frontal cortex: cross-talk between excitotoxicity and neuroinflammation. Neurochem. Res. 33 (2008) 2318-2323
179. Lee H.J., Rao J.S., Chang L., Rapoport S.I., and Bazinet R.P. Chronic N-methyl-d-aspartate administration increases the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat. J. Lipid Res. 49 (2008) 162-168
180. Rao J.S., Ertley R.N., Rapoport S.I., Bazinet R.P., and Lee H.J. Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2. J. Neurochem. 102 (2007) 1918-1927
181. Lazarewicz J.W., Salinska E., and Wroblewski J.T. NMDA receptor-mediated arachidonic acid release in neurons: role in signal transduction and pathological aspects. Adv. Exp. Med. Biol. 318 (1992) 73-89
182. Won S.J., Kim D.Y., and Gwag B.J. Cellular and molecular pathways of ischemic neuronal death. J. Biochem. Mol. Biol. 35 (2002) 67-86
183. H.C. Pan, T.K. Kao, Y.C. Ou, D.Y. Yang, Y.J. Yen, C.C.Wang, Y.H. Chuang, S.L. Liao, S.L. Raung, C.W.Wu, A.N. Chiang, C.J. Chen, Protective effect of docosahexaenoic acid against brain injury in ischemic rats, J. Nutr. Biochem. (in press) doi:10.1016/j.jnutbio.2008.06.014.
184. Shimazawa M., Nakajima Y., Mashima Y., and Hara H. Docosahexaenoic acid (DHA) has neuroprotective effects against oxidative stress in retinal ganglion cells. Brain Res. 1251 (2009) 269-275
185. N.G. Bazan, Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations and Alzheimer's disease, J. Lipid Res. (in press) doi:10.1194/jlr.R800068-JLR200.
186. Paul I.A., and Skolnick P. Glutamate and depression: clinical and preclinical studies. Ann. N. Y. Acad. Sci. 1003 (2003) 250-272
187. Pittenger C., Sanacora G., Krystal J.H., and The N. receptor as a therapeutic target in major depressive disorder. CNS Neurol. Disord. Drug Targets 6 (2007) 101-115
188. Maeng S., and Zarate Jr. C.A. The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Curr. Psychiatry Rep. 9 (2007) 467-474
189. Petrie R.X., Reid I.C., and Stewart C.A. The N-methyl-d-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review. Pharmacol. Ther. 87 (2000) 11-25
190. Rosa A.O., Lin J., Calixto J.B., Santos A.R., and Rodrigues A.L. Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behav. Brain Res. 144 (2003) 87-93
191. Cardoso C.C., Lobato K.R., Binfare R.W., Ferreira P.K., Rosa A.O., Santos A.R., and Rodrigues A.L. Evidence for the involvement of the monoaminergic system in the antidepressant-like effect of magnesium. Prog. Neuropsychopharmacol. Biol. Psychiatry 33 (2009) 235-242
192. Zomkowski A.D., Hammes L., Lin J., Calixto J.B., Santos A.R., and Rodrigues A.L. Agmatine produces antidepressant-like effects in two models of depression in mice. Neuroreport 13 (2002) 387-391
193. Almeida R.C., Felisbino C.S., Lopez M.G., Rodrigues A.L., and Gabilan N.H. Evidence for the involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice. Behav. Brain Res. 168 (2006) 318-322
194. Licinio J., and Wong M.L. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol. Psychiatry 4 (1999) 317-327
195. Parker G.B., Heruc G.A., Hilton T.M., Olley A., Brotchie H., Hadzi-Pavlovic D., Friend C., Walsh W.F., and Stocker R. Low levels of docosahexaenoic acid identified in acute coronary syndrome patients with depression. Psychiatry Res. 141 (2006) 279-286
196. Rogers P.J., Appleton K.M., Kessler D., Peters T.J., Gunnell D., Hayward R.C., Heatherley S.V., Christian L.M., McNaughton S.A., and Ness A.R. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial. Br. J. Nutr. 99 (2008) 421-431
197. Mischoulon D., Best-Popescu C., Laposata M., Merens W., Murakami J.L., Wu S.L., Papakostas G.I., Dording C.M., Sonawalla S.B., Nierenberg A.A., Alpert J.E., and Fava M. A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. Eur. Neuropsychopharmacol. 18 (2008) 639-645
198. Kurian M.A., Morgan N.V., MacPherson L., Foster K., Peake D., Gupta R., Philip S.G., Hendriksz C., Morton J.E., Kingston H.M., Rosser E.M., Wassmer E., Gissen P., and Maher E.R. Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). Neurology 70 (2008) 1623-1629
199. Shinzawa K., Sumi H., Ikawa M., Matsuoka Y., Okabe M., Sakoda S., and Tsujimoto Y. Neuroaxonal dystrophy caused by group VIA phospholipase A2 deficiency in mice: a model of human neurodegenerative disease. J. Neurosci. 28 (2008) 2212-2220